Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Obaid S Shaikh

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2021
Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infectionAdeel A Butt, Peng Yan, Rashid A Chotani, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 21, 2019
Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis CObaid S Shaikh, Shari Rogal, Anam Malik, et al.
Eclinicalmedicine|September 3, 2021
Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national populationAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Case Reports in Gastroenterology|November 30, 2020
Spontaneous Regression of Advanced Hepatocellular CarcinomaDhiraj J Sonbare, Rupal Bandi, Vivek Sharma, et al.
The Journal of Infectious Diseases|October 8, 2024
COVID-19 Disease Incidence and Severity in Persons Previously Infected and Unvaccinated vs Previously Uninfected and VaccinatedAdeel A Butt, Peng Yan, Abdul-Badi Abou-Samra, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2015
Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2019
Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES)Adeel A Butt, Peng Yan, Samia Aslam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2021
Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National PopulationAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Annals of Internal Medicine|July 19, 2021
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World SettingAdeel A Butt, Saad B Omer, Peng Yan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 2, 2016
Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2021
Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infectionAdeel A Butt, Peng Yan, Rashid A Chotani, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 21, 2019
Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis CObaid S Shaikh, Shari Rogal, Anam Malik, et al.
Eclinicalmedicine|September 3, 2021
Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national populationAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Case Reports in Gastroenterology|November 30, 2020
Spontaneous Regression of Advanced Hepatocellular CarcinomaDhiraj J Sonbare, Rupal Bandi, Vivek Sharma, et al.
The Journal of Infectious Diseases|October 8, 2024
COVID-19 Disease Incidence and Severity in Persons Previously Infected and Unvaccinated vs Previously Uninfected and VaccinatedAdeel A Butt, Peng Yan, Abdul-Badi Abou-Samra, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2015
Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2019
Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES)Adeel A Butt, Peng Yan, Samia Aslam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2021
Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National PopulationAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Annals of Internal Medicine|July 19, 2021
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World SettingAdeel A Butt, Saad B Omer, Peng Yan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 2, 2016
Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVESAdeel A Butt, Peng Yan, Obaid S Shaikh, et al.
Pageof 5